diabetestalk.net

Ascensia Diabetes Care Singapore

Presse

Presse

ASCENSIA DIABETES CARE AND HEALTH2SYNC ANNOUNCE COLLABORATION TO BRING DIGITAL DIABETES MANAGEMENT SOLUTION TO PATIENTS IN ASIA Basel, Switzerland and Taipei, Taiwan, November 28, 2017 Ascensia Diabetes Care and Health2Sync today announced a collaboration that aims to improve diabetes care by bringing an integrated digital management solution to patients in Asia. As part of this collaboration, the companies will create a combined offering for people with diabetes that comprises of the CONTOURPLUS or CONTOURTS blood glucose monitoring systems from Ascensia, the Health2Sync app and a loyalty program for users, known as the Ascensia Customer Care Program. Once the combined offering is launched, when people with diabetes purchase the CONTOURPLUS or CONTOURTS systems, they will be able to join the Ascensia Customer Care Program after registering for an account in the Health2Sync mobile app. Membership benefits include discount coupons for test strips, promotions and educational materials about diabetes. By using the Health2Sync app, people with diabetes will be able to log their blood glucose readings, track their blood glucose values, and make decisions related to diabetes management based on the analyses provided.A Bluetooth wireless technology enabled dongle from Health2Sync is also available. This dongle connects to the meter and allows data to be directly downloaded from the meter to the app. This collaboration with Health2Sync will enable us to bring an effective digital management solution to people with diabetes in Asia explained Michael Kloss, CEO, Ascensia Diabetes Care. By bringing together the accuracy and user friendly features of our meters with the innovative software capabilities in the Health2Sync app, we are able to provide significant value for people wit Continue reading >>

Ascensia Diabetes Care Holdings

Ascensia Diabetes Care Holdings

Implementing a successful global structure In early 2016, Ascensia Diabetes Care Holdings AG successfully established as a new company. This followed the completion of the acquisition by Panasonic Healthcare Holdings of the Diabetes Care business from Bayer. The tax side of the transaction was supported by a comprehensive Deloitte team. Deloitte assisted Panasonic Healthcare and KKR funds in the acquisition of the worldwide Diabetes Care business from Bayer. Deloittes support was not limited to the tax structuring services but was also actively involved in considerations around financing and a the selection of new global headquarters, named Ascensia Diabetes Care Holdings AG, located in Switzerland. The complexity of the transaction required continuous dedication from Deloitte teams across the globe and a strong collaboration with our client. Deloitte assisted our team on this transaction from day one and was always ready to adapt to new situations and circumstances. Even post-closing, we can still rely on the tax expertise of Deloitte for assistance during the implementation phase. Jan Vannerum, CFO/CAO, Ascensia Diabetes Care Holdings AG Continue reading >>

Ascensia | Contact Us

Ascensia | Contact Us

If you are a customer, job-seeker, partner or journalist, please use this section to find contact information and details about our regional corporate offices around the world. Questions or comments about this website, please CLICK HERE. An adverse event is any unwanted medical occurrence in a patient who has been given a pharmaceutical product or medical device. This can be any unfavourable and/or unintended sign, symptom, or complication associated with the use of the product. Adverse events should be reported immediately to a healthcare professional. Adverse events associated with an Ascensia Diabetes Care product should also be reported to Ascensia Diabetes Care contact details below: If you have any questions about the latest available blood glucose solutions, contact Ascensia Diabetes Care in your country. Visit contact.ascensia.com for a full listing of countries. Questions or comments about this website, please CLICK HERE. If you have any questions about the latest available blood glucose solutions, contact Ascensia Diabetes Care in your country. Visit contact.ascensia.com for a full listing of countries. Questions or comments about this website, please CLICK HERE. Please note that not all products are available in every country. The company that brings you CONTOURproducts now has a new name. Introducing Ascensia Diabetes Care. Ascensia, the Ascensia Diabetes Care logo and CONTOUR are trademarks of Ascensia Diabetes Care Holdings AG. Copyright 2017 Ascensia Diabetes Care Holdings AG. All rights reserved. Last updated: July 2016. Code: G.DC.01.2016.37920 Please note that not all products are available in every country. The company that brings you CONTOURproducts now has a new name. Introducing Ascensia Diabetes Care. Ascensia, the Ascensia Diabetes Care logo and Continue reading >>

Ascensia Announces Finalists For The Ascensia Diabetes Challenge Who Have The Potential To Revolutionize Type 2 Diabetes Management

Ascensia Announces Finalists For The Ascensia Diabetes Challenge Who Have The Potential To Revolutionize Type 2 Diabetes Management

Ascensia Announces Finalists For The Ascensia Diabetes Challenge Who Have The Potential To Revolutionize Type 2 Diabetes Management Ascensia Announces Finalists For The Ascensia Diabetes Challenge Who Have The Potential To Revolutionize Type 2 Diabetes Management BASEL, Switzerland, April 3, 2018 Today, Ascensia Diabetes Care has revealed the six entries that will progress to the finalist stage of the Ascensia Diabetes Challenge, a global innovation competition that is seeking digital solutions to support type 2 diabetes management. The six finalists were selected from 116 submissions that were received and were chosen by a panel consisting of external experts and members of the Ascensia Medical, R&D and Commercial teams. The selected companies will now present their solutions at the finalist event in April to determine the winner, which will subsequently be announced at the American Diabetes Association 78th Scientific Sessions in June. Weve received entries from entrepreneurs and start-ups around the world who are at the forefront of healthcare innovation. We have been delighted by the quality and variety of the submissions we have received, which offer digital solutions that could revolutionize a number of aspects of type 2 diabetes management, stated Michael Kloss, CEO of Ascensia Diabetes Care. We are now looking forward to the finalist event and hearing more about these truly innovative ideas. With type 2 diabetes currently accounting for around 90% of the estimated 425 million people with diabetes globally1, new innovative ways to manage this condition are urgently required to meet the substantial and growing burden to the individuals and our healthcare systems. Through the challenge, Ascensia is looking to support the companies and entrepreneurs developing the Continue reading >>

Diabetes Care

Diabetes Care

The protection and security of your personal data are important to Ascensia. This Privacy Statement tells you how we collect, use, share, and protect your personal data, and together with the website Terms and Conditions, applies to your use of Our Website is operated by Ascensia Diabetes Care Australia Pty Ltd, Suite 30, 215-219 George Street Liverpool 2170. NSW, who is the controller of your personal data processed via this Website. Ascensia is a subsidiary of Ascensia Diabetes Care Holdings AG of Switzerland. Please read this Privacy Statement to understand how Ascensia may process your personal data provided via our Website. You are not required to provide any personal data as a condition of using our Website. Where you submit personal data to us, Ascensia will process your personal data for the following purposes: Communications via our Website: If you complete an online registration or web form, where you contact us with an enquiry or request and similar situations in which you have chosen to provide the information to us, we will process the information to respond to your request including for customer services support. Products or Services You Request: Where you request a product or service from us, we will collect your personal data in order to process your request. Our distributors may also share with us personal data that you provide to them when you buy an Ascensia product or otherwise contact them following a purchase. When you communicate with us via our Website or request a product or service, the types of information we may collect from you include: your name, gender, date of birth, address, contact details including your email address, language preference and details of your communication or request. Product Warranty: We collect information you provide Continue reading >>

Cnw | Ascensia Diabetes Care Adds Further Experts To Judging Panel For Challenge And Expands Competition Into More Regions

Cnw | Ascensia Diabetes Care Adds Further Experts To Judging Panel For Challenge And Expands Competition Into More Regions

Ascensia Diabetes Care Adds Further Experts to Judging Panel for Challenge and Expands Competition Into More Regions BETHESDA, MD, Nov. 2, 2017 /CNW/ - Today, during the Diabetes Technology Meeting in Bethesda, MD, USA, Ascensia Diabetes Care announced two new judges that have been added to the judging panel for the Ascensia Diabetes Challenge, as it prepares for the competition to open for entries from the Americas and Asia Pacific. Healthcare innovation experts Dr Neal Kaufman, USA, and Dr Sidney Yee, Singapore, have both joined the judging panel for the competition. Dr Kaufman is an experienced clinician, public health academic and digital health executive, and is an expert in using technology to improve business and health outcomes. Dr Yee has expertise in the field of medical devices and healthcare technology, including significant experience bringing innovative diagnostic technologies to market. The Ascensia Diabetes Challenge is a global innovation competition that was launched on September 31, 2017. The challenge is seeking innovative digital solutions to support diabetes management and improve the lives of those living with type 2 diabetes. Finalists, runners-up and the winner will all receive cash prizes to support further development of their ideas from a total prize fund of 200,000. The winner will also have the opportunity to partner with Ascensia to further develop their solution. Neal Kaufman, MD, MPH, co-founder and Chief Medical Officer, Canary Health, Los Angeles, USA, explained, "Individuals with type 2 diabetes often have one or more chronic conditions impacting their health and their quality of life. People can improve their outcomes when they are able to effectively self-manage their lives, their relationships and their emotions. It is essential t Continue reading >>

Ascensia Diabetes Care And Health2sync Announce Collaboration To Bring Digital Diabetes Management Solution To Patients In Asia

Ascensia Diabetes Care And Health2sync Announce Collaboration To Bring Digital Diabetes Management Solution To Patients In Asia

Ascensia Diabetes Care and Health2Sync Announce Collaboration to Bring Digital Diabetes Management Solution to Patients in Asia BASEL, Switzerland and TAIPEI, Taiwan, November 28, 2017 /PRNewswire/ -- Ascensia Diabetes Care and Health2Sync today announced a collaboration that aims to improve diabetes care by bringing an integrated digital management solution to patients in Asia. As part of this collaboration, the companies will create a combined offering for people with diabetes that comprises of the CONTOURPLUS or CONTOURTS blood glucose monitoring systems from Ascensia, the Health2Sync app and a loyalty program for users, known as the Ascensia Customer Care Program. Once the combined offering is launched, when people with diabetes purchase the CONTOURPLUS or CONTOURTS systems, they will be able to join the Ascensia Customer Care Program after registering for an account in the Health2Sync mobile app. Membership benefits include discount coupons for test strips, promotions and educational materials about diabetes. By using the Health2Sync app, people with diabetes will be able to log their blood glucose readings, track their blood glucose values, and make decisions related to diabetes management based on the analyses provided. A Bluetooth wireless technology enabled dongle from Health2Sync is also available. This dongle connects to the meter and allows data to be directly downloaded from the meter to the app. "This collaboration with Health2Sync will enable us to bring an effective digital management solution to people with diabetes in Asia" explained Michael Kloss, CEO, Ascensia Diabetes Care. "By bringing together the accuracy and user friendly features of our meters with the innovative software capabilities in the Health2Sync app, we are able to provide significant Continue reading >>

Ascensia | Work For Us

Ascensia | Work For Us

As a dynamic, forward-thinking company, we are always looking for like-minded people to join us. If you share our passion for innovation and providing products and solutions that make a daily difference to the lives of people with diabetes, then consider a career with us. Ascensia Diabetes Care is a dynamic global company specialising in the research, development and marketing of high-quality solutions and precision tools that help patients manage their condition and take charge of their lives. If you are interested in joining an entrepreneurial and vibrant organisation that can help you achieve your full potential, please see our current opportunities around the world. To learn more about career opportunities at Ascensia in all countries, click below. Please note that you will be leaving the ascensia.com website when viewing a job opportunity. Established in 2016 through the acquisition of Bayer Diabetes Care by Panasonic Healthcare Holdings, Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes. Already including the world-renowned CONTOUR range of blood glucose monitoring meters, we are committed to adding more innovative and life-changing products to our portfolio. Throughout our 70-year history we have always been at the forefront of innovation in diabetes care. Find out more about our firsts and breakthroughs. If you have any questions about the latest available blood glucose solutions, contact Ascensia Diabetes Care in your country. Visit contact.ascensia.com for a full listing of countries. Questions or comments about this website, please CLICK HERE. If you have any questions about the latest available blood glucose solutions, contact Ascensia Diabetes Care in your country. Visit contact.ascensia.com for Continue reading >>

Panasonic Healthcare Holdings Has Chosen Ascensia Diabetes Care As The Name For The Diabetes Care Business That It Plans To Acquire From Bayer Ag

Panasonic Healthcare Holdings Has Chosen Ascensia Diabetes Care As The Name For The Diabetes Care Business That It Plans To Acquire From Bayer Ag

Panasonic Healthcare Holdings has chosen Ascensia Diabetes Care as the name for the Diabetes Care business that it plans to acquire from Bayer AG Panasonic Healthcare Holdings has chosen Ascensia Diabetes Care as the name for the Diabetes Care business that it plans to acquire from Bayer AG Ascensia Diabetes Care has been chosen to be the name for the new stand-alone company that will be formed from the diabetes care business that Panasonic Healthcare has agreed to acquire from Bayer AG Agreement between Panasonic Healthcare and Bayer first announced in June 2015 Deal to acquire the business remains on track for close in Q1 2016 Tokyo, August 7, 2015 Panasonic Healthcare Holdings, Co., Ltd. (PHCHD) today announced that Ascensia Diabetes Care has been chosen as the new name for the stand-alone company that is being formed from the Diabetes Care business it has agreed to acquire from Bayer Aktiengesellschaft (Bayer AG). PHCHD will be making necessary registrations and filings with the new company name to ensure business continuity upon closing of the acquisition. The new name follows the announcement in June 2015 that PHCHD, a company backed by funds sponsored by leading global investment firm Kohlberg Kravis Roberts & Co. (KKR) and Panasonic Corporation, entered into a definitive agreement to acquire the Diabetes Care business from Bayer AG. Todays announcement of the new company name is an important step on the transformative journey for this business. Once this deal has closed, Ascensia Diabetes Care will be home to world-renowned brands, a legacy of firsts in the diabetes community, and an existing and growing portfolio of products that will continue to innovate and lead the way in this field. The Ascensia name has historical significance for the Diabetes Care busine Continue reading >>

Ascensia Diabetes Care Singapore Private Limited

Ascensia Diabetes Care Singapore Private Limited

ASCENSIA DIABETES CARE SINGAPORE PRIVATE LIMITED Registration No. / Unique Entity Number: 201535215N ASCENSIA DIABETES CARE SINGAPORE PRIVATE LIMITED (the "Business") is a Private Company Limited by Shares, incorporated on 21 September 2015 (Monday) in Singapore. The address of the Business's registered office is at the PARKVIEW SQUARE building. The Business current operating status is live and has been operating for 2 years 351 days. The Business's principal activity is other health services n.e.c. (eg rehabilitation activities eg physiotherapy, chiropractic, speech therapy) with manufacture of medical research and clinical diagnostic instruments and supplies (eg reagents) as the secondary activity. ASCENSIA DIABETES CARE SINGAPORE PRIVATE LIMITED SGPBusiness.com is the No. 1 Business and Company Directory in Singapore, a full-service directory portal for business operations and sourcing.We provide information update to your listing, including business profile, website, contact details (phone, fax & email address), social media profile, of business or company profile, completely free of any fees or subscription charges.Your local business directories! All information and any services provided from sgpbusiness.com, its subdomain or all other pages under this domain are on an "as-is" and "as-available" basis without warranties of any kind and are made available for your general information and use only. While all effort is made to ensure that information provided is as accurate as possible, your use is entirely at your risk, for which SGPBusiness.com shall not be liable whatsoever.Our data may sometimes be cached or crawled, and republished by other sites which are not affiliated or related to us, and we cannot be responsible for their content. Additional Disclaimer: SG Continue reading >>

Ascensia Diabetes Challenge

Ascensia Diabetes Challenge

Do you have a digital solution for the global epidemic oftype 2 diabetes? Ascensia Diabetes Care has partnered with yet2 to launch the Ascensia Diabetes Challenge A GLOBAL INNOVATION COMPETITION. Weare seeking submissions for innovative digital solutions that can genuinely change behavior and improve the lives of people with type 2 diabetes. We want to support companies who are developing the next big leap forward in digital solutions for self-management of type 2 diabetes. The six entries that will progress to the finalist stage of the Ascensia Diabetes Challenge have been announced. The six finalists were selected from 116 submissions and chosen by a panel of external experts and members of the Ascensia Medical, R&D and Commercial teams. The selected entrants will receive 10,000 Euros for reaching this stage and are due to present their solutions at the finalist event in April to determine the winner. For more information, visit: www.ascensia.com/press/ . The Ascensia Diabetes Challenge has now closed for entries. Thank you to all the startups and entrepreneurs that submitted. Our judges will be reviewing the entries and selecting up to six finalists who will each receive a cash prize and be invited to our finalist event. Please check back later in March to hear who has reached the finalist stage. Submissions deadline now February 23, 2018 Entrants now have until Friday February 23, 2018 to submit their innovative, patient-centric, digital solutions to support diabetes management. Submit your entry for the Ascensia Diabetes Challenge below. Two new judges that have been announced for the Ascensia Diabetes Challenge. Healthcare innovation experts Dr Neal Kaufman, USA, and Dr Sidney Yee, Singapore, have both joined the judging panel for the competition. This comes as t Continue reading >>

Ascensia Diabetes Care Holdings Ag Key Developments

Ascensia Diabetes Care Holdings Ag Key Developments

Key Executives for Ascensia Diabetes Care Holdings AG Ascensia Diabetes Care Holdings AG does not have any Key Executives recorded. Ascensia Diabetes Care Holdings AG Key Developments Ascensia Diabetes Care Announces Commercial Agreement with DexCom, Inc. to Include CONTOURNEXT ONE BGMS with the Dexcom G5 Continuous Glucose Monitoring System for Patients Covered by Medicare Ascensia Diabetes Care announced that it has entered into an agreement with DexCom Inc. to provide the highly accurate Ascensia CONTOURNEXT ONE blood glucose monitoring system (BGMS) as part of the Dexcom G5 CGM System Medicare offering. The complete bundle will be available to people with diabetes who are covered by Medicare and qualify for therapeutic CGM. Dexcom G5 is currently the only CGM system approved by the FDA to meet the criteria for therapeutic CGM. Under the terms of the agreement, Ascensia Diabetes Care's CONTOURNEXT ONE BGMS will be provided to eligible people with diabetes in the bundle of supplies for the Dexcom G5 CGM System. The role of the CONTOURNEXT ONE BGMS will be to provide highly accurate readings for CGM calibration. The Dexcom G5 CGM System provides dynamic glucose information by showing a user his or her glucose level, along with both trend and rate of change information. People who use the G5 CGM System calibrate regularly to verify the CGM sensor reading is on track. Ascensia Diabetes Care and Voluntis Announce Technology Partnership to Help Optimize Insulin Management for People with Type 2 Diabetes Ascensia Diabetes Care and Voluntis announced a global technology partnership designed to help improve the lives of people with Type 2 diabetes by optimizing insulin management. This collaboration will connect the Voluntis basal insulin management solution for people with Continue reading >>

Panasonic Healthcare Holdings Completes Acquisition Of Leading Diabetes Care Business From Bayer Ag

Panasonic Healthcare Holdings Completes Acquisition Of Leading Diabetes Care Business From Bayer Ag

Panasonic Healthcare Holdings Completes Acquisition of Leading Diabetes Care Business from Bayer AG January 05, 2016 02:30 AM Eastern Standard Time TOKYO--( BUSINESS WIRE )--Panasonic Healthcare Holdings, Co., Ltd. (Panasonic Healthcare) and Bayer Aktiengesellschaft (Bayer AG) today announced the completion of Panasonic Healthcares acquisition of Bayer AGs Diabetes Care business. Panasonic Healthcare is backed by funds sponsored by leading global investment firm KKR and the Panasonic Corporation. The total consideration for the transaction is around EUR 1 billion (approximately 132 billion at the exchange rate of EUR1=132). The acquired Diabetes Care business will operate as a stand-alone company named Ascensia Diabetes Care that will provide high-quality solutions and precision tools to serve the needs of people with diabetes. Together Ascensia Diabetes Care and Panasonic Healthcare will develop, manufacture, market and sell blood glucose monitoring meters and strips for people with diabetes in more than 125 countries. Hidehito Kotani, President of Panasonic Healthcare said, Our goal is to ensure high-quality technologies and diabetes care solutions are available to all patients who need them. Bringing together Panasonic Healthcare and Ascensia Diabetes Care will significantly help to achieve this goal. Together with KKR, the companies will be able to serve more patients in more places across the globe with world-class products. We greatly look forward to expanding this business and innovating new solutions at this integral point in the diabetes care industry. Michael Kloss, Chief Executive Officer of Ascensia Diabetes Care, added, We are excited to launch as Ascensia Diabetes Care and continue to be a trustworthy provider of reliable, high-performance solutions that Continue reading >>

Lenovo Us Headquarters Address

Lenovo Us Headquarters Address

US. 6820 S. ex;it was commissioned to create an If you are looking for Bank Independent Inc Headquarter office address? or Bank Headquarters Address; GARMIN US Lenovo Corporate Office Headquarters Address;Lenovo Headquarters (Beijing) Campus B on www. S. Contact Us. Corporate Address. About us > Nestl worldwide; Number of shares: {0} 0. Insight global headquarters. Corporate Headquarters 44201 Nobel Drive Fremont, CA 94538. Save BIG with our app! Download Lenovo Laptop ASUS Laptop HUAWEI Laptop Acer Laptop Tablet Accessories Stand HolderLenovo India Phone Number Lenovo India Contact Number Official Address Email Address email to Lenovo India, tell us company with headquarters in Lenovo Is the Worlds #1 Provider of Educational Technology We Help School Districts US headquarters and Your email address will not be The challenges in merging the two companies also help explain Lenovo's decision to move its headquarters. SHOP SUPPORT. Sg blandt 300 forhandlere og find de bedste priser i dag!15-08-2018 Lenovo (Beijing) Limited develops, manufactures, and distributes information technology (IT) products and provides information technology services. The address is. Blog;North America. fujitsu. About Us. 0 $Billion. and ideally situated in a US Address: Lenovo Headquarters United States 1009 Think Pl. Rolls-Royce headquarters - Address and contact number for our head office. HEADQUARTERS. 5775 Morehouse Drive San Diego, We have several options for contacting us, Qualcomm products referenced on this page are products of Qualcomm Lenovo contact headquarters HQ office address, customer service number, toll free number, complaints, general enquiries phone number, email id. lenovo Our headquarters is located on the beautiful grounds of an old Austrian castle, AMS Footer / Address. Ge Continue reading >>

Ascensia Diabetes Care |privacy Policy

Ascensia Diabetes Care |privacy Policy

The protection and security of your personal data are important to Ascensia. This Privacy Statement tells you how we collect, use, share, and protect your personal data, and together with the website Terms and Conditions, applies to your use of and . Our Website is operated by Ascensia Diabetes Care India Private Limited LE (Ascensia) of 1st Floor, Bella Vista, Oswal Park, Pokhran Road No.2, Majiwada Junction, Thane (W)-400601, India, who is the controller of your personal data processed via this Website. Ascensia is a subsidiary of Ascensia Diabetes Care Holdings AG of Switzerland. Please read this Privacy Statement to understand how Ascensia may process your personal data provided via our Website. You are not required to provide any personal data as a condition of using our Website. Where you submit personal data to us, Ascensia will process your personal data for the following purposes: Communications via our Website: If you complete an online registration or web form, where you contact us with an enquiry or request and similar situations in which you have chosen to provide the information to us, we will process the information to respond to your request including for customer services support. Products or Services You Request: Where you request a product or service from us, we will collect your personal data in order to process your request. Our distributors may also share with us personal data that you provide to them when you buy an Ascensia product or otherwise contact them following a purchase. When you communicate with us via our Website or request a product or service, the types of information we may collect from you include: your name, gender, date of birth, address, contact details including your email address, language preference and details of your commun Continue reading >>

More in diabetes